Status:
COMPLETED
Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO
Lead Sponsor:
Dr. Alexander Supady
Conditions:
COVID-19
SARS-CoV 2
Eligibility:
All Genders
18-100 years
Brief Summary
The prognosis of patients with severe COVID-19 disease, whose lungs are so severely diseased that they need to be supported by veno-venous ECMO (extracorporeal membrane oxygenation), is difficult to a...
Detailed Description
In December 2019, a series of unexplained cases of pneumonia in the city of Wuhan in China has come to light. In virologic analyses of samples from the patients' deep respiratory tract, a novel corona...
Eligibility Criteria
Inclusion
- patient admitted to ICU
- initiation of vv-ECMO
- definite SARS-CoV-2-infection
Exclusion
- none
Key Trial Info
Start Date :
May 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
133 Patients enrolled
Trial Details
Trial ID
NCT04405973
Start Date
May 19 2020
End Date
September 30 2020
Last Update
November 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Clinic Freiburg
Freiburg im Breisgau, Germany, 79106